UBS Updates Exchange Rate Fixing Time for ETRACS Alerian Midstream Energy Index ETN due June 21, 2050

NEW YORK–(BUSINESS WIRE)–On June 30, 2020, Alerian announced an update to the methodology guide for the Alerian Midstream Energy Index (the “Index”). Effective as of the close of business on June 30, 2020, the Index began using the WM/Reuters USD/CAD foreign exchange rate as of 4:00 p.m. Eastern Time (rather than 4:00 p.m. London Time) to convert the value of Canadian index constituent securities, for purposes of determining the Index values.

Subsequent to the Index methodology update, UBS Securities LLC, in its capacity as calculation agent for the ETRACS Alerian Midstream Energy Index ETN due June 21, 2050 (Ticker: AMNA) (the “Securities”) today announced a change to the USD/CAD foreign exchange rate fixing time for the Securities following a determination that the prior USD/CAD foreign exchange rate used to convert the cash value of distributions on Canadian index constituent securities is no longer economically representative for purposes of the Securities. Effective as of July 13, 2020, the USD/CAD foreign exchange rate used for the purpose of determining the cash value of distributions on Canadian index constituent securities on the relevant ex-dividend date will be the WM/Reuters USD/CAD foreign exchange rate as of 4:00 pm Eastern Time (rather than 4:00 p.m. London Time).

For more information on the ETNs:

AMNA Prospectus Supplement

About ETRACS

ETRACS ETNs are senior unsecured notes issued by UBS AG, are traded on NYSE Arca, and can be bought and sold through a broker or financial advisor. An investment in ETRACS ETNs is subject to a number of risks, including the risk of loss of some or all of the investor’s principal, and is subject to the creditworthiness of UBS AG. Investors are not guaranteed any coupon or distribution amount under the ETNs. We urge you to read the more detailed explanation of risks described under “Risk Factors” in the applicable prospectus supplement, or product supplement and pricing supplement, as applicable, for the ETRACS ETN.

UBS AG has filed a registration statement (including a prospectus and supplements thereto) with the Securities and Exchange Commission, or SEC, for the offerings of securities to which this communication relates. Before you invest, you should read the prospectus, along with the applicable prospectus, pricing, or product supplement to understand fully the terms of the securities and other considerations that are important in making a decision about investing in the securities. The applicable offering document for the securities may be obtained by clicking on the hyperlink above. You may also get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. The securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.

About UBS

UBS provides financial advice and solutions to wealthy, institutional and corporate clients worldwide, as well as private clients in Switzerland. UBS’s strategy is centered on our leading global wealth management business and our premier universal bank in Switzerland, enhanced by Asset Management and the Investment Bank. The bank focuses on businesses that have a strong competitive position in their targeted markets, are capital efficient, and have an attractive long-term structural growth or profitability outlook.

UBS is present in all major financial centers worldwide. It has offices in more than 50 regions and locations, with about 31% of its employees working in the Americas, 32% in Switzerland, 19% in the rest of Europe, the Middle East and Africa and 18% in Asia Pacific. UBS Group AG employs over 67,000 people around the world. Its shares are listed on the SIX Swiss Exchange and the New York Stock Exchange (NYSE).

This material is issued by UBS AG and/or any of its subsidiaries and/or any of its affiliates (“UBS”). Products and services mentioned in this material may not be available for residents of certain jurisdictions. Past performance is not necessarily indicative of future results. Please consult the restrictions relating to the product or service in question for further information. Activities with respect to US securities are conducted through UBS Securities LLC, a US broker/dealer. Member of SIPC (http://www.sipc.org/).

ETRACS ETNs are sold only in conjunction with the relevant offering materials. UBS has filed a registration statement (including a prospectus, as supplemented by the applicable prospectus supplement, or product supplement and pricing supplement, for the offering of the ETRACS ETNs) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read these documents and any other documents that UBS has filed with the SEC for more complete information about UBS and the offering to which this communication relates. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, you can request the applicable prospectus supplement, or product supplement and pricing supplement, by calling toll-free (+1-877-387 2275). In the US, securities underwriting, trading and brokerage activities and M&A advisor activities are provided by UBS Securities LLC, a registered broker/dealer that is a wholly owned subsidiary of UBS AG, a member of the New York Stock Exchange and other principal exchanges, and a member of SIPC. UBS Financial Services Inc. is a registered broker/dealer and affiliate of UBS Securities LLC.

Alerian Midstream Energy Index and AMNA are trademarks of Alerian and their use is granted under a license from Alerian.

UBS specifically prohibits the redistribution or reproduction of this material in whole or in part without the prior written permission of UBS and UBS accepts no liability whatsoever for the actions of third parties in this respect.

© UBS 2020. The key symbol, UBS and ETRACS are among the registered and unregistered trademarks of UBS. Other marks may be trademarks of their respective owners. All rights reserved.

1 Individual investors should instruct their broker/advisor/custodian to call us or should call together with their broker/advisor/custodian.

Contacts

Media
Christina Aquilina

1-212-713-4488

christina.aquilina@ubs.com

Institutional Investors1
+1-877-387 2275

Author: dmnnewswire